| Literature DB >> 31991543 |
Ji Min Kim1, Jeong Hun Kim2, Sung-Chan Shin3, Gi Cheol Park4, Hyung Sik Kim5,6, Keunyoung Kim7, Hyoung Kyu Kim8, Jin Han8, Natalia P Mishchenko9, Elena A Vasileva9, Sergey A Fedoreyev9, Valentin A Stonik9, Byung-Joo Lee1,3.
Abstract
Here, we investigated the effects of sex hormones on extracellular matrix (ECM)-related gene expression in the vocal fold lamina propria of ovariectomized (after ovary removal) rats and verified whether echinochrome A (ECH) exerts any therapeutic effects on ECM reconstitution after estrogen deficiency in ovariectomized rats. Sprague-Dawley female rats (9 weeks old) were acclimatized for a week and randomly divided into three groups (n = 15 each group) as follows: group I (sham-operated rats, SHAM), group II (ovariectomized rats, OVX), group III (ovariectomized rats treated with ECH, OVX + ECH). Rats from the OVX + ECH group were intraperitoneally injected with ECH at 10 mg/kg thrice a week after surgery for 6 weeks. And rats were sacrificed 6 weeks after ovariectomy. Estradiol levels decreased in OVX group compared with the SHAM group. ECH treatment had no effect on the levels of estradiol and expression of estrogen receptor β (ERβ). The evaluation of ECM components showed no significant changes in elastin and hyaluronic acid levels between the different groups. Collagen I and III levels were lower in OVX group than in SHAM group but increased in OVX + ECH group. The mRNA levels of matrix metalloproteinase (MMP)-1, -2, -8, and -9 were significantly higher in the OVX group than in the SHAM group, but decreased in the OVX + ECH group. Thus, changes were observed in ECM-related genes in the OVX group upon estradiol deficiency that were ameliorated by ECH administration. Thus, the vocal fold is an estradiol-sensitive target organ and ECH may have protective effects on the ECM of vocal folds in ovariectomized rats.Entities:
Keywords: echinochrome A; estradiol; extracellular matrix; ovariectomy; vocal fold
Year: 2020 PMID: 31991543 PMCID: PMC7073970 DOI: 10.3390/md18020077
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118